Legal & General Group
TNXP icon

Legal & General Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Legal & General Group’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8K Buy
1,470
+417
+40% +$5.38K ﹤0.01% 3152
2026
Q1 		$14.5K Hold
1,053
– – ﹤0.01% 3085
2025
Q4 		$16.4K Buy
1,053
+220
+26% +$4.06K ﹤0.01% 3105
2025
Q3 		$20.1K Buy
833
+144
+21% +$5.34K ﹤0.01% 3030
2025
Q2 		$24.7K Buy
+689
New +$18.1K ﹤0.01% 2921
2022
Q3 		– Hold
0
– -$2K – 3489
2022
Q2 		– Hold
0
– – – 3491
2022
Q1 		– Hold
0
– – – 3432
2021
Q4 		– Hold
0
– – – 3411
2021
Q3 		– Hold
0
– – – 3314
2021
Q2 		– Hold
0
– – – 3151

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Legal & General Group's TNXP Position: Q2 2026 in Review

Legal & General Group increased its Tonix Pharmaceuticals (TNXP) stake by 40% in Q2 2026, buying an estimated $5.38K and bringing the position to 1,470 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3152.

Legal & General Group first reported a position in TNXP in Q2 2025 and has held it in 5 quarters since. The position peaked at $24.7K in Q2 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Legal & General Group held 1,470 shares of Tonix Pharmaceuticals worth $18.8K as of Q2 2026.
  • Legal & General Group bought 417 Tonix Pharmaceuticals shares in Q2 2026, an estimated $5.38K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3152 holding.
  • Legal & General Group first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Legal & General Group's Tonix Pharmaceuticals position peaked at $24.7K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.